{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Huntsville",
      "state": "TX",
      "country": "United States",
      "classification": "Class I",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "98256",
      "recalling_firm": "StuffbyNainax",
      "address_1": "2830 Lake Rd Apt 1102",
      "address_2": "N/A",
      "postal_code": "77340-5662",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Press Release",
      "distribution_pattern": "Product was distributed to 4 customers in the US.",
      "recall_number": "D-0397-2026",
      "product_description": "MR. 7 SUPER 700000 capsules, 1 capsule blister card, Distributed by mR. 7",
      "product_quantity": "4",
      "reason_for_recall": "Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared sildenafil and tadalafil",
      "recall_initiation_date": "20251215",
      "center_classification_date": "20260318",
      "report_date": "20260311",
      "code_info": "All codes; Exp 12/31/2029"
    }
  ]
}